Mark Lakshmanan is an Endocrinology/Metabolic physician affiliated with Eli Lilly. OpenAlex indexes 79 publications with 7,684 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1955 Mulsanne Drive
Zionsville, IN 46077
Telephone
317-873-4801Registry record last updated 8 Oct 2008.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
Cardiovascular Diabetology
2021 - Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial
The Lancet Diabetes & Endocrinology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Flora Sam, MD
Eli Lilly
Alessandro Biffi, MD
Eli Lilly
Ann Hake, MD
Eli Lilly
Kevin Biglan, MD
Eli Lilly
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”